BAZ2A Antibody Polyclonal

<strong>BAZ2A Antibody Polyclonal</strong>_x000D_ <strong>Catalog number:</strong> B2016913_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µL_x000D_ <strong>Molecular Weight or Concentration:</strong> 270 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> TIP5, WALp3_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Mayer C, Neubert M, Grummt I. The structure of NoRC-associated RNA is crucial for targeting the chromatin remodelling complex NoRC to the nucleolus EMBO Rep. 2008 Aug;9(8):774-80._x000D_ 2: Pe√±a-Hern√°ndez R, Aprigliano R, Carina Frommel S, Pietrzak K, Steiger S, Roganowicz M, Lerra L, Bizzarro J, Santoro R. BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells EMBO Rep. 2021 Nov 4;22(11):e53014._x000D_ 3: Dalcher D, Tan JY, Bersaglieri C, Pe√±a-Hern√°ndez R, Vollenweider E, Zeyen S, Schmid MW, Bianchi V, Butz S, Roganowicz M, Kuzyakiv R, Baubec T, Marques AC, Santoro R. BAZ2A safeguards genome architecture of ground-state pluripotent stem cells EMBO J. 2020 Dec 1;39(23):e105606._x000D_ 4: Roganowicz M, B√§r D, Bersaglieri C, Aprigliano R, Santoro R. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer Life Sci Alliance. 2023 Apr 25;6(7):e202301950._x000D_ 5: Dalle Vedove A, Cazzanelli G, Batiste L, Marchand JR, Spiliotopoulos D, Corsi J, D'Agostino VG, Caflisch A, Lolli G. Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing ACS Med Chem Lett. 2022 Aug 3;13(9):1434-1443._x000D_ 6: Cazzanelli G, Vedove AD, Parolin E, D'Agostino VG, Unzue A, Nevado C, Caflisch A, Lolli G. Reevaluation of bromodomain ligands targeting BAZ2A Protein Sci. 2023 Sep;32(9):e4752._x000D_ 7: Dalle Vedove A, Cazzanelli G, Corsi J, Sedykh M, D'Agostino VG, Caflisch A, Lolli G. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining ACS Bio Med Chem Au. 2021 Dec 15;1(1):5-10._x000D_ 8: Spiliotopoulos D, Wamhoff EC, Lolli G, Rademacher C, Caflisch A. Discovery of BAZ2A bromodomain ligands Eur J Med Chem. 2017 Oct 20;139:564-572._x000D_ 9: Jia Y, Li L, Lin YH, Gopal P, Shen S, Zhou K, Yu X, Sharma T, Zhang Y, Siegwart DJ, Ready JM, Zhu H. In¬†vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration Cell Stem Cell. 2022 Mar 3;29(3):372-385.e8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38750323">10: Gross P. Regulation of chromatin domains by BAZ2A Nat Genet. 2024 May;56(5):737. </a>_x000D_ _x000D_ <strong>Products Related to BAZ2A Antibody Polyclonal can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>